Swelling of the Right Arm During a Nuclear Medicine Therapy for Metastatic Pheochromocytoma.
作者信息
Yu Run, Gardner Linda, Ells Zachary, Dahlbom Magnus, Salavati Ali, Bahri Shadfar
机构信息
Division of Endocrinology, UCLA David Geffen School of Medicine, Los Angeles, California.
Ahmanson Translational Imaging Division, UCLA David Geffen School of Medicine, Los Angeles, California.
出版信息
AACE Clin Case Rep. 2024 Nov 18;11(1):75-76. doi: 10.1016/j.aace.2024.11.003. eCollection 2025 Jan-Feb.
Abstract
摘要
相似文献
1
Swelling of the Right Arm During a Nuclear Medicine Therapy for Metastatic Pheochromocytoma.转移性嗜铬细胞瘤核医学治疗期间右臂肿胀
AACE Clin Case Rep. 2024 Nov 18;11(1):75-76. doi: 10.1016/j.aace.2024.11.003. eCollection 2025 Jan-Feb.
2
Complete remission of metastatic pheochromocytoma in I-metaiodobenzylguanidine scintigraphy after a single session of I-metaiodobenzylguanidine therapy: a case report.单次碘-间位碘代苄胍治疗后碘-间位碘代苄胍闪烁显像中转移性嗜铬细胞瘤完全缓解：一例报告
BMC Res Notes. 2017 Dec 19;10(1):750. doi: 10.1186/s13104-017-3095-6.
3
Special situations in pheochromocytomas and paragangliomas: pregnancy, metastatic disease, and cyanotic congenital heart diseases.嗜铬细胞瘤和副神经节瘤的特殊情况：妊娠、转移疾病和发绀性先天性心脏病。
Clin Exp Med. 2022 Aug;22(3):359-370. doi: 10.1007/s10238-021-00763-3. Epub 2021 Sep 30.
4
Paroxysmal hypertension with concomitant swelling of the thyroid due to pheochromocytoma of the right adrenal gland; cure by surgical removal of the pheochromocytoma.右侧肾上腺嗜铬细胞瘤导致阵发性高血压并伴有甲状腺肿大；通过手术切除嗜铬细胞瘤治愈。
J Clin Endocrinol Metab. 1947 Jan;7(1):30-46. doi: 10.1210/jcem-7-1-30.
5
High-Specific-Activity-I-MIBG versus Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma.高比活度碘-131 间碘苄胍与镥- DOTATATE 靶向放射性核素治疗转移性嗜铬细胞瘤和副神经节瘤。
Clin Cancer Res. 2021 Jun 1;27(11):2989-2995. doi: 10.1158/1078-0432.CCR-20-3703. Epub 2021 Mar 8.
6
Complete Remission in Metastatic Pheochromocytoma Treated with Extensive Surgery.广泛手术治疗转移性嗜铬细胞瘤后的完全缓解
Cureus. 2016 Jan 5;8(1):e447. doi: 10.7759/cureus.447.
7
Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.嗜铬细胞瘤和副神经节瘤的核医学：处于精准医学的十字路口
Endocr Relat Cancer. 2023 Feb 20;30(4). doi: 10.1530/ERC-22-0375. Print 2023 Apr 1.
8
Synchronous liver metastasis at initial diagnosis of adrenal pheochromocytoma by CT: A case report.肾上腺嗜铬细胞瘤初诊时CT发现同步肝转移：一例报告
Oncol Lett. 2024 May 17;28(1):329. doi: 10.3892/ol.2024.14462. eCollection 2024 Jul.
9
Combination chemotherapy regimen in a patient with metastatic malignant pheochromocytoma and neurofibromatosis type 1.一名转移性恶性嗜铬细胞瘤合并1型神经纤维瘤病患者的联合化疗方案
Am J Case Rep. 2014 Mar 25;15:123-7. doi: 10.12659/AJCR.890181. eCollection 2014.
10
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Management of Metastatic and/or Unresectable Pheochromocytoma and Paraganglioma.北美神经内分泌肿瘤学会共识指南：转移性和/或不可切除的嗜铬细胞瘤和副神经节瘤的监测和管理。
Pancreas. 2021 Apr 1;50(4):469-493. doi: 10.1097/MPA.0000000000001792.
本文引用的文献
1
Tissue dose estimation after extravasation of Lu-DOTATATE.镥[¹⁷⁷Lu]奥曲肽外渗后的组织剂量估算。
EJNMMI Phys. 2021 Mar 31;8(1):33. doi: 10.1186/s40658-021-00378-3.
2
Effective Management of 177Lu-DOTA0-Tyr3-Octreotate Extravasation.177Lu-DOTA0-Tyr3-Octreotate 外渗的有效处理
Clin Nucl Med. 2021 Feb 1;46(2):144-145. doi: 10.1097/RLU.0000000000003452.
3
Salvage PRRT with Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival.用 Lu-DOTA-octreotate 对广泛预处理的转移性神经内分泌肿瘤 (NET) 患者进行挽救性 PRRT：剂量学、毒性、疗效和生存。
BMC Cancer. 2019 Aug 8;19(1):788. doi: 10.1186/s12885-019-6000-y.
Zotero 插件